Seamlessly combines diverse biological data types, including genomics, transcriptomics, proteomics, and real-world clinical data, into a unified analytical framework.
Uses machine learning models to analyze integrated datasets and prioritize novel therapeutic targets with high biological plausibility and druggability.
Identifies potential biomarkers from complex data to predict disease progression, patient subgroups, or treatment response.
Analyzes real-world clinical and healthcare data to generate insights on disease patterns, treatment outcomes, and patient journeys.
Provides a secure environment for research teams to share data, run analyses, visualize results, and collaborate on projects.
Pharmaceutical researchers use Zephyr AI to analyze tumor genomics and proteomics data alongside patient outcomes to identify novel cancer drug targets. The platform's AI models uncover dysregulated pathways and potential vulnerabilities in cancer cells that may not be evident through conventional methods. This accelerates the identification of high-priority targets for further preclinical validation.
Academic and biotech researchers leverage the platform to integrate sparse multi-omics data from rare disease patients. By connecting genetic variants with phenotypic data, Zephyr AI helps hypothesize disease mechanisms and identify repurposable existing drugs or new therapeutic avenues for conditions with limited research history.
Clinical development teams use the tool to analyze pre-treatment patient data to discover predictive biomarkers. These biomarkers can be used to stratify patients in clinical trials, enriching the patient population most likely to respond to a therapy, thereby improving trial efficiency and success rates.
Healthcare analytics professionals apply Zephyr AI's real-world evidence capabilities to study treatment sequences and outcomes in large patient populations. This helps understand the effectiveness of existing therapies in diverse settings and can identify unmet medical needs or opportunities for new intervention strategies.
Universities and biopharma companies collaborate using the platform to jointly analyze proprietary and public datasets. The secure, shared environment facilitates data pooling and advanced AI analysis without transferring raw data, enabling partnerships that accelerate translational research from bench to bedside.
Sign in to leave a review
15Five operates in the people analytics and employee experience space, where platforms aggregate HR and feedback data to give organizations insight into their workforce. These tools typically support engagement surveys, performance or goal tracking, and dashboards that help leaders interpret trends. They are intended to augment HR and management decisions, not to replace professional judgment or context. For specific information about 15Five's metrics, integrations, and privacy safeguards, you should refer to the vendor resources published at https://www.15five.com.
20-20 Technologies is a comprehensive interior design and space planning software platform primarily serving kitchen and bath designers, furniture retailers, and interior design professionals. The company provides specialized tools for creating detailed 3D visualizations, generating accurate quotes, managing projects, and streamlining the entire design-to-sales workflow. Their software enables designers to create photorealistic renderings, produce precise floor plans, and automatically generate material lists and pricing. The platform integrates with manufacturer catalogs, allowing users to access up-to-date product information and specifications. 20-20 Technologies focuses on bridging the gap between design creativity and practical business needs, helping professionals present compelling visual proposals while maintaining accurate costing and project management. The software is particularly strong in the kitchen and bath industry, where precision measurements and material specifications are critical. Users range from independent designers to large retail chains and manufacturing companies seeking to improve their design presentation capabilities and sales processes.
3D Generative Adversarial Network (3D-GAN) is a pioneering research project and framework for generating three-dimensional objects using Generative Adversarial Networks. Developed primarily in academia, it represents a significant advancement in unsupervised learning for 3D data synthesis. The tool learns to create volumetric 3D models from 2D image datasets, enabling the generation of novel, realistic 3D shapes such as furniture, vehicles, and basic structures without explicit 3D supervision. It is used by researchers, computer vision scientists, and developers exploring 3D content creation, synthetic data generation for robotics and autonomous systems, and advancements in geometric deep learning. The project demonstrates how adversarial training can be applied to 3D convolutional networks, producing high-quality voxel-based outputs. It serves as a foundational reference implementation for subsequent work in 3D generative AI, often cited in papers exploring 3D shape completion, single-view reconstruction, and neural scene representation. While not a commercial product with a polished UI, it provides code and models for the research community to build upon.
